Cargando…

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV

Hepatic steatosis (HS) related to nonalcoholic fatty liver disease (NAFLD) is increasing globally. In people living with human immunodeficiency virus (PLWH) risk factors of HS are increased. The impact of HS on outcomes and in particular health‐related quality of life (HRQL) in PLWH remains unknown....

Descripción completa

Detalles Bibliográficos
Autores principales:	Michel, Maurice, Labenz, Christian, Anders, Malena, Wahl, Alisha, Girolstein, Lisann, Kaps, Leonard, Kremer, Wolfgang M., Huber, Yvonne, Galle, Peter R., Sprinzl, Martin, Schattenberg, Jörn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315116/ https://www.ncbi.nlm.nih.gov/pubmed/35411570 http://dx.doi.org/10.1002/hep4.1958

Ejemplares similares

Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2023)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Health-related quality of life in patients with autoimmune hepatitis
por: Michel, Maurice, et al.
Publicado: (2021)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Risk factors for poorer health literacy in patients with liver cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2021)

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis
por: Kremer, Wolfgang M., et al.
Publicado: (2020)

Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
por: Michel, Maurice, et al.
Publicado: (2021)

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
por: Labenz, Christian, et al.
Publicado: (2020)

Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
por: Labenz, Christian, et al.
Publicado: (2020)

Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

Development and evaluation of a virtual reality driving test for patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies
por: Labenz, Christian, et al.
Publicado: (2020)

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Labenz, Christian, et al.
Publicado: (2021)

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
por: Kaps, Leonard, et al.
Publicado: (2022)

Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low‐Density Lipoprotein Cholesterol
por: Labenz, Christian, et al.
Publicado: (2019)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
por: Kaps, Leonard, et al.
Publicado: (2022)

Portal vein thrombosis is associated with an increased risk of bone fractures
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany
por: Tilch, Marie-Kristin, et al.
Publicado: (2021)

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders
por: Gairing, Simon Johannes, et al.
Publicado: (2021)

Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
por: Kaps, Leonard, et al.
Publicado: (2020)

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care
por: Kaps, L., et al.
Publicado: (2021)

Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2023)

The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
por: Michel, Maurice, et al.
Publicado: (2021)

Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives
por: Nagel, Michael, et al.
Publicado: (2020)

A higher FIB‐4 index is associated with an increased incidence of renal failure in the general population
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
por: Nagel, Michael, et al.
Publicado: (2023)

Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study
por: Kremer, Wolfgang M., et al.
Publicado: (2021)

Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters – an animal model of life style intervention in NAFLD
por: Gehrke, Nadine, et al.
Publicado: (2019)

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis
por: Nagel, Michael, et al.
Publicado: (2022)

Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation
por: Nagel, Michael, et al.
Publicado: (2022)

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort
por: Steinebrunner, Niels, et al.
Publicado: (2015)

Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation
por: Gehrke, Nadine, et al.
Publicado: (2016)

Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study
por: Pfirrmann, Daniel, et al.
Publicado: (2019)

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B
por: Sprinzl, Martin F., et al.
Publicado: (2021)

Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population‐Based Study in Germany
por: Huber, Yvonne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vlq1l4tap8af44ps4d6e0vh0fv